Acute Care Alberta extends contract with private surgery clinic at centre of conflict of interest probes
The Alberta agency overseeing acute care has granted a six-month contract extension to a private surgical clinic whose previous provincial government contracts are the subject of several ongoing probes.
In a $1.7-million wrongful dismissal lawsuit filed in February, ousted former AHS CEO Athana Mentzelopoulos alleges she received political pressure to renew contracts with chartered surgical facilities (CSFs) that she believed were overpriced. Her lawsuit alleges she had been fired after launching an investigation into various contracts with links to government officials.
Alberta's auditor general, Alberta Health Services (AHS) and a retired Manitoba judge appointed by the province are among the agencies investigating the province's health procurement and contracting processes.
Mentzelopoulos raised concerns about several issues with different contracts, including a orthopedic surgery contract signed with an Edmonton-based company, Alberta Surgical Group (ASG). She alleges AHS was paying higher rates per procedure compared to other vendors.
Alberta Health Minister Adriana LaGrange and AHS have filed statements of defence in the Court of King's Bench, denying the allegations. They said Mentzelopoulos was fixated on suspicions of wrongdoing, and standing in the way of the government's plan to restructure Alberta's health system.
Mentzelopoulos has refuted these claims.
Neither Alberta Surgical Group, nor any of the company's owners, responded to requests for comment about the contract extension on Wednesday. The company has previously denied any conflicts or wrongdoing.
Health minister says Edmonton needs surgical capacity
When the allegations became public in February, an AHS spokesperson said the authority had paused the awarding of surgical contracts under review, then later clarified that the pause was limited to "new surgical contracts."
ASG was under contract from November 1, 2022, to April 30, 2025, to perform orthopedic surgeries in the Edmonton area. The maximum value of the contract for the entire time period is listed at about $70.5 million, but details of each procedure's cost are redacted from the publicly posted agreement.
Alberta Surgical Group has a private surgical clinic in Heritage Valley, on Edmonton's south side. It has contracts with public health agencies to perform publicly funded orthopedic and ear, nose and throat surgeries. (Jamie McCannel/CBC)
On April 1, the government transferred the authority to sign surgical contracts over to the new Acute Care Alberta agency, which will be responsible for overseeing hospital-based care and CSFs in the province.
On Monday, LaGrange's press secretary said Acute Care Alberta had extended ASG's contract for six months.
In the legislature on Tuesday, Premier Danielle Smith said the many ongoing investigations had delayed the startup of a new private surgical centre scheduled to open on the Enoch Cree Nation, just west of Edmonton.
"We're not going to cancel thousands of surgeries for hip and knee replacements," she said.
LaGrange told reporters Wednesday the Enoch facility had already won a bid to provide surgeries in the Edmonton area once it was up and running, which it is expected to be in 2026.
Her press secretary said in a statement that extending the contract with ASG for six months gives Acute Care Alberta time to finish contract negotiations with Enoch, and allows retired Manitoba Justice Raymond Wyant's government-ordered investigation to conclude.
LaGrange said Wednesday the province needs to keep thousands of surgeries going at ASG to tackle the long wait times for orthopedic procedures.
"While we are completing over 60 per cent [of surgeries] in clinically approved times, we want that number to get to 100 per cent," she said.
Cost of contract extension not public
The details of the contract aren't yet public. Alberta Health Services has posted copies of previous CSF contracts online, including details such as the estimated total cost, and the maximum cost the vendor can charge for services.
Neither LaGrange nor Acute Care Alberta would say how much the contract is for, the cost per procedure, or the volume and type of procedures ASG is expected to perform.
Acute Care Alberta spokesperson Holly Budd said a version of the contract will be posted publicly once it is "fully executed."
LaGrange said Alberta is moving to a health funding model where service providers are paid based on the volume of work they do partly to shed more light on the cost of care.
NDP health critic Sarah Hoffman told reporters Wednesday it is "completely inappropriate" for a provincial agency to extend a contract with ASG while so many related investigations are underway. Hoffman said health agencies had time to formulate a backup plan to provide surgeries elsewhere.
"We have hospital operating rooms that aren't working full capacity. They could staff up and properly move forward with public health care, but they're choosing to continue full speed ahead at privatization, and that's wrong," she said.
While criticizing public hospitals' ability to complete more surgeries, the government has also made it more difficult for AHS to do procedures, Hoffman said, including an unwillingness to pay for overnight coverage for patients to have joint replacement surgeries at the Royal Alexandra Hospital's Orthopedic Surgical Centre.
Keeping secret the details of the contracts also fosters public distrust, Hoffman said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15 hours ago
- Yahoo
'Can't stop': Researchers say problematic smartphone use like an addiction
EDMONTON — Anita Hagh couldn't stop pressing the corner of her phone screen where the Facebook app used to be. It was about five years ago, and she had deleted the social media platform from her cellphone. It was like muscle memory, she says, having clicked on the app countless times so she could scroll for hours through random online groups. She realized she had been losing out on sleep while scrolling and made the difficult decision to delete the app. "After deleting it, I was very much thinking it was still there, kind of like a phantom limb situation," said the 28-year-old post-doctoral researcher at McGill University's department of integrated studies in education. Hagh, who is researching the addictive nature of social media, said she believes she was likely experiencing what's called "problematic smartphone use" or phone addiction. Jay Olson, a post-doctoral researcher in the University of Toronto's psychology department, led a 2023 global study that surveyed more than 50,000 people about their smartphone habits. He said it's an emerging problem. "Normal smartphone use would become problematic when it starts negatively affecting your daily life and in different ways," said Olson. "It might make you feel depressed. It might be interfering with your sleep or your concentration." Some young adults are showing symptoms of problematic smartphone use, Olson said, as they've never seen a world without phones or have spent most of their lives with the devices. "Smartphones started to become more popular around 2009," he said. "A bunch of kids across the world got these phones. And so now we're starting to see what some of these effects might be." It's harder for older generations to understand the magnitude of the problem and how using phones can become an ingrained habit, Olson added. "(They) haven't grown up using smartphones and social media for the majority of their free time throughout the day," he said. Venture Academy, a private school for troubled teens with locations in Barrie, Ont., and Red Deer, Alta., offers treatment for problems including "electronic addiction." Gary Su, a clinical therapist with the school, said in an interview from Calgary that smartphone use has made the lives of many of his young clients more complex. "We are seeing a very unique phenomenon," he said. "Things seem to be a lot more volatile or more extreme. Kids are exposed to things just way too early for their age. And it's harder to trace, because everything online is anonymous." He said some students are using their phones so much they have difficulty socializing. Some don't leave their bedrooms for hours, because they're busy texting after school, he said. Su said phones stop others from spending time with their families, and online bullying has become rampant. Some are also sharing intimate photos and details at an earlier age, which continues to haunt them years later due to the permanent nature of the online world, he said. "I see a lot of family just come in because of phone addiction or problematic phone use," Su said. "I feel for the parents. Most of us are not tech geniuses." Problematic smartphone use hasn't been officially classified as an addiction in the Diagnostic and Statistical Manual of Mental Disorders, the reference book used by mental health professionals around the world. "There isn't consensus among researchers right now," said Olson, adding it's because the problem is so new. However, he said there is some agreement that problematic smartphone use shares similarities with different behavioural addictions. "So often people report this compulsion, like when they wake up, they have to check their phone right away," Olson said. "They can't stop themselves." Su said some of his patients could be classified as phone addicts. "Addiction is when you are doing something that you know has negative consequences and you can't stop yourself from using it," he said. "I see a lot of youth I work with fit in that category. I tend to not label it, because labelling is not doing any good." Olson said there needs to be more discussion about smartphone habits. Cellphone bans in schools across Canada are a good start, Olson added, but more needs to be done by governments, such as putting age limits on social media platforms. "I certainly think that it's an important contributor to this decline in mental health that we're seeing," he said. Hagh said she's keeping track of her phone habits, as she's still on social media for her research. "It is very addicting. These platforms have been optimized to capture as much attention ... and arguably create an addiction. "It's kind of like having to watch a train crash or a car crash," she added. "You just can't look away." This report by The Canadian Press was first published June 8, 2025. Fakiha Baig, The Canadian Press Sign in to access your portfolio
Indianapolis Star
15 hours ago
- Indianapolis Star
FDA: More cucumbers, ready-to-eat products recalled in growing salmonella outbreak
A Maryland food company has recalled specific salsa and cucumber products because they were made with cucumbers that are possibly contaminated with salmonella. TGD Cuts, LLC of Jessup, Maryland, is recalling some tub and tray products because they contained cucumbers from Boynton Beach, Florida-based Bedner Growers Inc., which have been linked to a salmonella outbreak. TGD Cuts distributed the affected products, which included salsas, sliced cucumbers and cucumber spears, to retail and foodservice locations in Maryland, Virginia, Pennsylvania, New Jersey, and North Carolina, according to the Food and Drug Administration (FDA). The products had use-by dates ranging from May 20 to May 28 and are unlikely to be in stores or being used. No illnesses have been reported in connection with the products, the FDA said. Egg recall: Brown eggs sold at some Walmart stores have salmonella risk The initial May 19 recall involved cucumbers sold directly to consumers at Bednar's Farm Fresh Market, according to notices published May 19 by the Centers for Disease Control and Prevention (CDC) and the FDA. Subsequent recalls have been announced by grocers such as Harris Teeter, Kroger and Walmart for repackaged cucumbers for resale under different brand names or those used in ready-to-eat products, including vegetable trays and salads. The cucumbers, distributed by Fresh Start Produce Sales of Delray, Florida, also led to Target recalling individual cucumbers on May 30, specifically cucumber two-packs and various prepared foods products. In addition to the growing cucumber-related recall, other products have been recalled recently for potential salmonella contamination. The FDA on May 28 upgraded a recall of tomatoes distributed in three southern states to a Class I recall, meaning consumption of the food could cause serious health complications or lead to death. Then, on June 6, the CDC and FDA linked brown eggs sold in nine states – including at some Walmart stores – to an ongoing Salmonella Enteritidis outbreak, in which 79 people have been sickened and at least 21 hospitalized. Customers who purchased any products from TGD Cuts should get rid of them or return them for a full refund. Here is the list of products recalled due to a possible salmonella risk. Salmonella poisoning causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms, which include diarrhea, fever and stomach cramps, will usually occur six hours to six days after exposure and may last up to seven days. Symptoms from severe infections may include aches, headaches, elevated fever, lethargy, rashes, and blood in urine or stool. Mike Snider is a reporter on USA TODAY's Trending team. You can follow him on Threads, Bluesky, X and email him at mikegsnider & @ & @mikesnider & msnider@
